New Meta-analysis: Ivermectin Poised as Promising Treatment for COVID-19 | WHAT REALLY HAPPENED

New Meta-analysis: Ivermectin Poised as Promising Treatment for COVID-19

A recent systematic review and meta-analysis published in the American Journal of Therapeutics parsed the data of multiple studies seeking to find if the anti-parasitic drug Ivermectin showed efficacy in the treatment of Coronavirus Disease 2019 (COVID-19). The examination of data showed promising results.

Ivermectin is widely used in low and middle income countries to treat worm infections, in addition to scabies and lice, says the study. The drug’s benign safety profile has allowed it to be administered so many times that total doses amount to nearly a third of the planetary population.

Ivermectin is considered to be extremely safe in humans. Indeed, its creators were awarded a Nobel Prize in 2015 for its discovery.

According to the study, Ivermectin, in addition to being an anti-parasitic drug, also has significant antiviral effects against other RNA and DNA viruses, such as Dengue, Yellow Fever, and Zika. One study researchers analyzed found the active mechanism for the drug’s antiviral properties is its ability to block the nuclear import of viral proteins. However, this was only demonstrated in vitro, or in lab experiments, and has not yet been confirmed in vivo, or inside the body.